CY1845A - Substituted 1h-imidazoles - Google Patents

Substituted 1h-imidazoles

Info

Publication number
CY1845A
CY1845A CY184596A CY184596A CY1845A CY 1845 A CY1845 A CY 1845A CY 184596 A CY184596 A CY 184596A CY 184596 A CY184596 A CY 184596A CY 1845 A CY1845 A CY 1845A
Authority
CY
Cyprus
Prior art keywords
alkyl
hydrogen
compounds
methyl
imidazole
Prior art date
Application number
CY184596A
Other languages
English (en)
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of CY1845A publication Critical patent/CY1845A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Resins (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CY184596A 1986-11-04 1996-03-08 Substituted 1h-imidazoles CY1845A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868626287A GB8626287D0 (en) 1986-11-04 1986-11-04 Substituted 1h-imidazoles

Publications (1)

Publication Number Publication Date
CY1845A true CY1845A (en) 1996-03-08

Family

ID=10606751

Family Applications (1)

Application Number Title Priority Date Filing Date
CY184596A CY1845A (en) 1986-11-04 1996-03-08 Substituted 1h-imidazoles

Country Status (24)

Country Link
US (1) US4814343A (fi)
EP (1) EP0269599B1 (fi)
JP (1) JP2632877B2 (fi)
KR (1) KR910003116B1 (fi)
AT (1) ATE98640T1 (fi)
AU (1) AU592733B2 (fi)
CA (1) CA1301174C (fi)
CY (1) CY1845A (fi)
DE (1) DE3788507T2 (fi)
DK (1) DK166584B1 (fi)
ES (1) ES2060608T3 (fi)
FI (1) FI91858C (fi)
GB (1) GB8626287D0 (fi)
HK (1) HK78895A (fi)
HU (1) HU206684B (fi)
IE (1) IE61901B1 (fi)
IL (1) IL84322A (fi)
MY (1) MY102578A (fi)
NO (1) NO169960C (fi)
NZ (1) NZ222382A (fi)
PL (3) PL155119B1 (fi)
PT (1) PT86040B (fi)
SU (4) SU1662349A3 (fi)
ZA (1) ZA878170B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0249772A (ja) * 1988-04-07 1990-02-20 Glaxo Group Ltd イミダゾール誘導体
GB8810067D0 (en) * 1988-04-28 1988-06-02 Ucb Sa Substituted 1-(1h-imidazol-4-yl)alkyl-benzamides
JPH04252867A (ja) * 1991-01-25 1992-09-08 Nissan Motor Co Ltd 内燃機関の燃料供給装置
GB9310965D0 (en) * 1993-05-27 1993-07-14 Ucb Sa 2-hydroxy-3-(1h-imidazol-4-yl)alkyl)benzenecarboximidamides
ATE234290T1 (de) * 1993-11-15 2003-03-15 Schering Corp Phenylalkyl-imidazole als h3-rezeptor- antagonisten
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
WO2008086131A1 (en) * 2007-01-12 2008-07-17 Allergan, Inc. Naphthylmethylimidizoles as therapeutic agents
US7868020B2 (en) * 2007-01-12 2011-01-11 Allergan, Inc. Quinolynylmethylimidizoles as therapeutic agents
US8119807B2 (en) * 2007-01-12 2012-02-21 Allergan, Inc. Quinolynylmethylimidizoles as therapeutic agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US29761A (en) * 1860-08-28 Improvements in telegraphic apparatus
US4062967A (en) 1974-02-07 1977-12-13 Smith Kline & French Laboratories Limited Bis-guanidino-alkane compounds
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
DE4224020A1 (de) * 1992-07-22 1994-01-27 Deutsche Aerospace Verfahren zur Auslösung der Zündung eines Gefechtskopfes und Anordnung zum Durchführen des Verfahrens

Also Published As

Publication number Publication date
JP2632877B2 (ja) 1997-07-23
NO874572L (no) 1988-05-05
DE3788507D1 (de) 1994-01-27
PT86040B (pt) 1990-07-31
PT86040A (pt) 1987-11-01
DK166584B1 (da) 1993-06-14
HU206684B (en) 1992-12-28
NO874572D0 (no) 1987-11-03
IL84322A0 (en) 1988-03-31
FI874789A0 (fi) 1987-10-30
ATE98640T1 (de) 1994-01-15
FI874789A (fi) 1988-05-05
IE872963L (en) 1988-05-04
EP0269599B1 (fr) 1993-12-15
PL268558A1 (en) 1988-09-01
DK572987D0 (da) 1987-11-02
SU1710558A1 (ru) 1992-02-07
EP0269599A3 (en) 1990-03-14
SU1662349A3 (ru) 1991-07-07
AU8059387A (en) 1988-05-05
IL84322A (en) 1991-08-16
KR880006205A (ko) 1988-07-22
PL156483B1 (en) 1992-03-31
FI91858B (fi) 1994-05-13
PL155119B1 (en) 1991-10-31
NO169960C (no) 1992-08-26
NZ222382A (en) 1991-07-26
ZA878170B (en) 1989-07-26
US4814343A (en) 1989-03-21
FI91858C (fi) 1994-08-25
HK78895A (en) 1995-05-26
PL156482B1 (pl) 1992-03-31
GB8626287D0 (en) 1986-12-03
JPS63132876A (ja) 1988-06-04
AU592733B2 (en) 1990-01-18
DE3788507T2 (de) 1994-05-19
HUT56547A (en) 1991-09-30
CA1301174C (en) 1992-05-19
SU1635899A3 (ru) 1991-03-15
KR910003116B1 (ko) 1991-05-18
EP0269599A2 (fr) 1988-06-01
DK572987A (da) 1988-05-05
SU1628857A3 (ru) 1991-02-15
NO169960B (no) 1992-05-18
MY102578A (en) 1992-07-31
ES2060608T3 (es) 1994-12-01
IE61901B1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
IE811250L (en) Imidazole derivatives
ZA878170B (en) Substituted 1h-imidazoles
AU2058283A (en) 2-amino-3-acylamino-6-benzylamino pyridine derivatives
IE780145L (en) Meta-sulphonamido-benzamides
AU581438B2 (en) Substituted pyrrolidinones, processes for their preparation and pharmaceutical compositions
ES8705396A1 (es) Procedimiento para la obtencion de imidazoles sustituidos
DE3572808D1 (en) 4-(nitrophenyl)-tetrahydropyridines, process for their preparation and their application as pharmaceutical compounds
ES8500923A1 (es) Procedimiento para la preparacion de derivados de acido fenilacetico
IE821475L (en) Benzoyl-phenyl-piperidine derivatives
IE801382L (en) Piperidines.
AU557772B2 (en) I-furyl-3,4-dihydroisoquinolines
ES477709A1 (es) Procedimiento de preparacion de nuevos compuestos cis- y trans-1,5-benzotiacepinicos.
AU2155383A (en) Acridanone derivatives